Adjuvant therapy with pembrolizumab in renal cell carcinoma: real-world experiences from a retrospective, multi-institutional cohort.
Mattigk A, Cano Garcia C, Klümper N, Cox A, Hahn O, Junker K, Erdmann K, Schmucker P, Flegar L, Zengerling F, Banek S, Ellinger J, Buerk BT, Huber J, Kalogirou C, Zeuschner P, Hoeh B.
Mattigk A, et al. Among authors: huber j.
Urol Int. 2024 Dec 24:1-21. doi: 10.1159/000543278. Online ahead of print.
Urol Int. 2024.
PMID: 39719131